Anavex Life Sciences Income Statement (2010-2025) | AVXL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating items
Research & Development (Quarter)	6.72M	8.96M	9.37M	8.66M	8.60M	9.27M	11.38M	12.07M	11.31M	10.28M	10.06M	8.68M	9.73M	11.81M	11.61M	10.45M	9.89M	9.96M	7.29M	4.66M
Selling, General & Administrative (Quarter)	2.23M	2.43M	2.88M	3.07M	2.92M	3.19M	3.90M	3.32M	2.88M	3.25M	2.60M	2.69M	2.90M	2.79M	2.66M	3.15M	2.62M	4.50M	3.55M	2.13M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	8.95M	11.40M	12.25M	11.72M	11.52M	12.46M	15.28M	15.38M	14.19M	13.53M	12.66M	11.38M	12.62M	14.60M	14.27M	13.59M	12.51M	14.46M	10.84M	6.78M
Operating Income (Quarter)				-11.72M	-11.52M	-12.46M	-15.28M	-15.38M	-14.19M	-13.53M	-12.66M	-11.38M	-12.62M	-14.60M	-14.27M	-13.59M	-12.51M	-14.46M	-10.84M	-5.66M
EBIT (Quarter)	-8.13M	-10.14M	-11.58M	-11.72M	-11.52M	-12.46M	-15.28M	-15.38M	-14.19M	-13.53M	-12.66M	-11.38M	-12.62M	-14.60M	-14.27M	-13.59M	-12.51M	-14.46M	-10.84M	-5.66M
Non-operating items
Other Non Operating Income (Quarter)	-0.15M	-0.16M	-0.28M	0.06M	0.27M	-0.73M	-0.50M	0.37M	-0.12M		-0.19M	0.16M	-0.15M	0.07M	0.12M	-0.34M	0.01M	-0.01M	0.01M	0.01M
Non Operating Income (Quarter)	0.83M	1.26M	0.68M	0.87M	1.11M	0.18M	1.20M	2.39M	1.13M	2.29M	2.44M	2.76M	2.08M	2.39M	2.65M	1.48M	1.32M	1.22M	1.02M	1.12M
Net income details
EBT (Quarter)	-8.13M	-10.14M	-11.58M	-10.85M	-10.41M	-12.28M	-14.08M	-12.99M	-13.06M	-11.24M	-10.21M	-8.54M	-10.44M	-12.28M	-11.74M	-13.59M	-12.51M	-14.46M	-10.84M	-5.66M
Tax Provisions (Quarter)	0.03M	0.04M	0.14M	0.03M	0.03M	0.09M	0.21M	-0.02M	0.05M	0.04M	-0.06M	0.09M	0.10M	-0.07M						0.02M
Profit After Tax (Quarter)	-8.16M	-10.18M	-11.72M	-10.88M	-10.44M	-12.37M	-14.29M	-12.97M	-13.11M	-11.28M	-10.15M	-8.62M	-10.55M	-12.21M	-11.62M	-12.11M	-11.20M	-13.24M	-9.83M	-5.68M
Income from Continuing Operations (Quarter)	-8.16M	-10.18M	-11.72M	-10.88M	-10.44M	-12.37M	-14.29M	-12.97M	-13.11M	-11.28M	-10.15M	-8.62M	-10.55M	-12.21M	-11.74M	-13.59M	-12.51M	-14.46M	-10.84M	-5.68M
Consolidated Net Income (Quarter)	-8.16M	-10.18M	-11.72M	-10.88M	-10.44M	-12.37M	-14.29M	-12.97M	-13.11M	-11.28M	-10.15M	-8.62M	-10.55M	-12.21M	-11.74M	-13.59M	-12.51M	-14.46M	-10.84M	-5.68M
Income towards Parent Company (Quarter)	-8.16M	-10.18M	-11.72M	-10.88M	-10.44M	-12.37M	-14.29M	-12.97M	-13.11M	-11.28M	-10.15M	-8.62M	-10.55M	-12.21M	-11.74M	-13.59M	-12.51M	-14.46M	-10.84M	-5.68M
Net Income towards Common Stockholders (Quarter)	-8.16M	-10.18M	-11.72M	-10.88M	-10.44M	-12.37M	-14.29M	-12.97M	-13.11M	-11.28M	-10.15M	-8.62M	-10.55M	-12.21M	-11.74M	-13.59M	-12.51M	-14.46M	-10.84M	-5.68M
Additional items
EPS (Basic) (Quarter)	-0.12	-0.14	-0.15	-0.14	-0.14	-0.16	-41.06	-0.17	-0.17	-0.14	-0.13	-0.11	-0.13	-0.14	-0.14	-0.14	-0.13	-0.16	-0.11	-0.06
EPS (Weighted Average and Diluted) (Quarter)			-0.17				-0.19	-0.17	-0.17	-0.14	-0.13	-0.11	-0.13	-0.14	-0.14	-0.14	-0.13	-0.16	-0.11	-0.06
Shares Outstanding (Weighted Average) (Quarter)	68.59M	70.59M	69.80M	76.00M	76.25M	77.44M	0.35M	77.98M	78.30M	80.88M	79.79M	82.08M	82.27M	83.02M	83.47M	84.81M	85.07M	85.09M	0.01M	89.03M
Shares Outstanding (Diluted Average) (Quarter)			69.80M				76.91M	77.98M	78.14M	79.05M	79.79M	82.08M	82.46M	83.02M	83.47M	84.81M	84.94M	85.09M	85.29M	89.03M
EBITDA (Quarter)	-8.13M	-10.14M	-11.58M	-11.72M	-11.52M	-12.46M	-15.28M	-15.38M	-14.19M	-13.53M	-12.66M	-11.38M	-12.62M	-14.60M	-14.27M	-13.59M	-12.51M	-14.46M	-10.84M	-5.66M
Tax Rate (Quarter)	-0.33%	-0.38%	-1.23%	-0.28%	-0.29%	-0.72%	-1.49%	0.15%	-0.38%	-0.36%	0.63%	-1.00%	-1.01%	0.55%						-0.32%

Research Tools

Anavex Life Sciences Income Statement (2010-2025) | AVXL

Create an account

Sign In

Reset Password